Form 4: Arvinas Director Briggs Morrison Reports Changes in Beneficial Ownership
SEC Form 4
Director Briggs Morrison reports acquisition of restricted stock units and stock options in Arvinas, Inc.
Summary
- On May 29, 2024, Briggs Morrison, a director of Arvinas, Inc., reported changes in beneficial ownership.
- Morrison acquired 5,899 shares of common stock through restricted stock units (RSUs) at a price of $0.
- These RSUs vest on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
- Morrison also acquired options to purchase 9,070 shares of common stock at an exercise price of $33.90, also vesting on the earlier of May 29, 2025, or the first board meeting after the next annual stockholder meeting.
- Following these transactions, Morrison directly owns 29,996 shares of common stock and options to purchase 9,070 shares.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a routine filing indicating standard compensation practices. The acquisition of shares and options suggests a positive outlook from the director, but it's not overwhelmingly bullish.
Positives
- The acquisition of RSUs and stock options by a director signals confidence in the company's future performance.
- The vesting schedule aligns the director's interests with the long-term success of the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future performance.
Comparison to Industry Standards
- Stock option and RSU grants are a common form of compensation for directors and executives in publicly traded companies, particularly in the biotechnology industry.
- Vesting schedules tied to continued service are standard practice to incentivize long-term commitment.
- The size of the grant is typical for a director at a company of Arvinas' size and stage.
Stakeholder Impact
- The transactions have a minor positive impact on shareholders as they align the director's interests with the company's performance.
- There is no immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 05/29/2024 | Date of transaction: Acquisition of restricted stock units and stock options. |
| 05/29/2025 | Vesting date for RSUs and stock options (or the first board meeting after the next annual stockholder meeting, if earlier). |
| 05/28/2034 | Expiration date for the stock options. |
| 05/30/2024 | Date of the Limited Power of Attorney for Section 16 Reporting Obligations. |
| 05/31/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.